Effect of sample delivery conditions on Renin-Angiotensin-Aldosterone System (RAAS) assay

References

• Pugliese NR, Masi S, Taddei S. The renin-angiotensin-aldosterone system: a crossroad from arterial hypertension to heart failure. Heart Fail Rev. 2020;25(1):31–42.
   PubMed Web of Science ®Google Scholar
• Paul M, Poyan Mehr A, Kreutz R. Physiology of local renin-angiotensin systems. Physiol Rev. 2006;86(3):747–803.
   PubMed Web of Science ®Google Scholar
• Jaisser F, Farman N. Emerging roles of the mineralocorticoid receptor in pathology: toward new paradigms in clinical pharmacology. Pharmacol Rev. 2016;68(1):49–75.
   PubMed Web of Science ®Google Scholar
• Padia SH, Kemp BA, Howell NL, et al. Conversion of renal angiotensin II to angiotensin III is critical for AT2 receptor-mediated natriuresis in rats. Hypertension. 2008;51(2):460–465.
   PubMed Web of Science ®Google Scholar
• Luther JM. Aldosterone in vascular and metabolic dysfunction. Curr Opin Nephrol Hypertens. 2016;25(1):16–21.
   PubMed Web of Science ®Google Scholar
• Pantzaris ND, Karanikolas E, Tsiotsios K, et al. Renin inhibition with Aliskiren: a decade of clinical experience. J Clin Med. 2017; 6(6):pii:E61.
   PubMed Web of Science ®Google Scholar
• Laudisio A, Giovannini S, Finamore P, et al. Use of ACE-inhibitors and quality of life in an older population. J Nutr Health Aging. 2018;22(10):1162–1166.
   PubMed Web of Science ®Google Scholar
• Markan U, Pasupuleti S, Pollard CM, et al. The place of ARBs in heart failure therapy: is aldosterone suppression the key? Ther Adv Cardiovasc Dis. 2019;13:1–7:PMID:31401939.
   Google Scholar
• Zhao D, Liu H, Dong P, et al. A meta-analysis of add-on use of spironolactone in patients with resistant hypertension. Int J Cardiol. 2017;233:113–117.
   PubMed Web of Science ®Google Scholar
• Montori VM, Young WF. Jr. Use of plasma aldosterone concentration-to-plasma renin activity ratio as a screening test for primary aldosteronism. Endocrinol Metab Clin North Am. 2002;31(3):619–632.
   PubMed Web of Science ®Google Scholar
• Perschel FH, Schemer R, Seiler L, et al. Rapid screening test for primary hyperaldosteronism: ratio of plasma aldosterone to renin concentration determined by fully automated chemiluminescence immunoassays. Clin Chem. 2004;50(9):1650–1655.
   PubMed Web of Science ®Google Scholar
• Maiolino G, Rossitto G, Bisogni V, et al. Quantitative value of aldosterone-renin ratio for detection of aldosterone-producing adenoma: the aldosterone-renin ratio for primary aldosteronism (AQUARR) study. J Am Heart Assoc. 2017;6:e005574.
   PubMed Web of Science ®Google Scholar
• Li T, Ma Y, Zhang Y, et al. Feasibility of screening primary aldosteronism by aldosterone-to-direct renin concentration ratio derived from chemiluminescent immunoassay measurement: diagnostic accuracy and cutoff value. Int J Hypertens. 2019;2019:1–8.
   Web of Science ®Google Scholar
• Drayer JI, Benraad TJ. The reliability of the measurement of plasma renin activity by radioimmunoassay. Clin Chim Acta. 1975;61(3):309–324.
   PubMed Web of Science ®Google Scholar
• Burrello J, Monticone S, Buffolo F, et al. Diagnostic accuracy of aldosterone and renin measurement by chemiluminescent immunoassay and radioimmunoassay in primary aldosteronism. J Hypertens. 2016;34(5):920–927.
   PubMed Web of Science ®Google Scholar
• Dorrian CA, Toole BJ, Alvarez-Madrazo S, et al. A screening procedure for primary aldosteronism based on the Diasorin Liaison automated chemiluminescent immunoassay for direct renin. Ann Clin Biochem. 2010;47(3):195–199.
   PubMed Web of Science ®Google Scholar
• Lin DC, Raizman JE, Holmes DT, et al. Evaluation of a chemiluminescent immunoassay for urinary aldosterone on the DiaSorin LIAISON automated platform against RIA and LC-MS/MS. Clin Chem Lab Med. 2017;55(8):e181–e183.
   PubMed Web of Science ®Google Scholar
• Morganti A. European study group for the validation of DiaSorin LIAISON Direct Renin Assay. A comparative study on inter and intralaboratory reproducibility of renin measurement with a conventional enzymatic method and a new chemiluminescent assay of immunoreactive renin. J Hypertens. 2010;28:1307–1312.
   PubMed Web of Science ®Google Scholar
• Gruson D, Maisin D, Lison P, et al. Two-site automated chemiluminescent assay for measurement of immunoreactive renin. Biomarkers. 2011;16(7):605–609.
   PubMed Web of Science ®Google Scholar
• Fischer E, Reuschl S, Quinkler M, et al. Assay characteristics influence the aldosterone to renin ratio as a screening tool for primary aldosteronism: results of the German Conn’s registry. Horm Metab Res. 2013;45:526–531.
   PubMed Web of Science ®Google Scholar
• Hurwitz S, Potter B, Weiss RJ, et al. Influence of sodium intake on the reliability of active renin as a measure of the renin-angiotensin system in essential hypertension. Am J Clin Pathol. 2001;115(2):304–312.
   PubMed Web of Science ®Google Scholar
• Sedman T, Heinla K, Vasar E, et al. Liraglutide treatment may affect renin and aldosterone release. Horm Metab Res. 2017;49:5–9.
   PubMed Web of Science ®Google Scholar
• Toering TJ, Gant CM, Visser FW, et al. Sex differences in renin-angiotensin-aldosterone system affect extracellular volume in healthy subjects. Am J Physiol Renal Physiol. 2018;314(5):F873–F878.
   PubMed Web of Science ®Google Scholar
• Braithwaite JE, Yandle TG, Nicholls MG, et al. Interference by o-phenanthroline in the radioimmunoassay of angiotensin II in small volume blood samples. Clin Biochem. 2012;45(1–2):168–170.
   PubMed Web of Science ®Google Scholar
• Glinicki P, Jeske W, Gietka-Czernel M, et al. The effect of blood collection procedure on plasma renin activity (PRA) and concentrations of direct renin (DRC) and aldosterone. J Renin Angiotensin Aldosterone Syst. 2015;16(2):339–343.
   PubMed Web of Science ®Google Scholar
• Locsei Z, Racz K, Patocs A, et al. Influence of sampling and storage conditions on plasma renin activity and plasma renin concentration. Clin Chim Acta. 2009;402(1–2):203–205.
   PubMed Web of Science ®Google Scholar
• Brossaud J, Corcuff JB. Pre-analytical and analytical considerations for the determination of plasma renin activity. Clin Chim Acta. 2009;410(1–2):90–92.
   PubMed Web of Science ®Google Scholar
• Shimamoto K, Ishida H, Nakahashi Y, et al. A very sensitive direct radioimmunoassay system for plasma angiotensin II and its clinical application in various hypertensive diseases. Jpn Circ J. 1984;48(11):1228–1235.
   PubMedGoogle Scholar
• Belaidi N, Georges A, Brossaud J, et al. Aldosterone determination: comparison of a RIA assay and a CLIA assay. Clin Biochem. 2015;48(1–2):89–92.
   PubMed Web of Science ®Google Scholar